Search Results - "Olesen, Ole F."

Vaccine Hesitancy among Healthcare Workers in Europe: A Systematic Review by Kaur, Mandeep, Coppeta, Luca, Olesen, Ole F

“…This study analyzes vaccine hesitancy (VH) among healthcare workers (HCWs) in 15 European countries. We have undertaken a systematic review by synthesizing…”
Get full text

European & Developing Countries Clinical Trials Partnership (EDCTP) by Olesen, Ole F.

Get full text

Strengthening health research capacity in sub-Saharan Africa: mapping the 2012-2017 landscape of externally funded international postgraduate training at institutions in the region by Morel, Terra, Maher, Dermot, Nyirenda, Thomas, Olesen, Ole F

“…The objective was to guide key stakeholders on future directions of external funding of international postgraduate training (Master's and PhD) of health…”
Get full text

A Mechanism for Reviewing Investments in Health Research Capacity Strengthening in Low- and Middle-Income Countries by Kilmarx, Peter H, Maitin, Thabi, Adam, Taghreed, Akuffo, Hannah, Aslanyan, Garry, Cheetham, Michael, Corrêa-Oliveira, Rodrigo, Kay, Simon, Khelef, Nadia, Kunaratnam, Yaso, Kupfer, Linda, Olesen, Ole F

“…More than 40 agencies that fund health research capacity strengthening in low- and middle-income countries (LMICs) participate in the ESSENCE Health Research…”
Get full text

Low Rates of Immunity among Medical Students and Residents in the Era of the Resurgence of Measles by Ferrari, Cristiana, Somma, Giuseppina, Caputi, Vittorio, Treglia, Michele, Pallocci, Margherita, Cenko, Fabian, Buonomo, Ersilia, Carestia, Mariachiara, Di Giampaolo, Luca, Olesen, Ole F, Coppeta, Luca

“…Measles is a highly contagious viral disease spread through respiratory droplets. The number of reported cases increased worldwide in 2023, particularly in the…”
Get full text

Increasing European Support for Neglected Infectious Disease Research by Olesen, Ole F., Ackermann, Marit

“…Neglected infectious diseases (NIDs) are a persistent cause of death and disability in low-income countries. Currently available drugs and vaccines are often…”
Get full text

The status of tuberculosis vaccine development by Schrager, Lewis K, Vekemens, Johan, Drager, Nick, Lewinsohn, David M, Olesen, Ole F

“…Tuberculosis represents the leading global cause of death from an infectious agent. Controlling the tuberculosis epidemic thus represents an urgent global…”
Get full text

Research and capacity building for control of neglected tropical diseases: the need for a different approach by Kariuki, Thomas, Phillips, Richard, Njenga, Sammy, Olesen, Ole F, Klatser, Paul R, Porro, Riccardo, Lock, Sarah, Cabral, Maria Hermínia, Gliber, Martina, Hanne, Detlef

“…The workshops were organized under the framework of the European Foundation Initiative for African Research into Neglected Tropical Diseases (EFINTD,…”
Get full text

Calling on Europe to support operational research in low-income and middle-income countries by Quaglio, GianLuca, Ramsay, Andy, Harries, Anthony D, Karapiperis, Theodoros, Putoto, Giovanni, Dye, Chris, Olesen, Ole F, Tomson, Göran, Zachariah, Rony

Get full text

The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships by Fernow, Josepine, Olliver, Marie, Couet, William, Lagrange, Sophie, Lamers, Meindert H, Olesen, Ole F, Orrling, Kristina, Pieren, Michel, Sloan, Derek J, Vaquero, Juan José, Miles, Timothy J, Karlén, Anders

“…The AMR Accelerator is an Innovative Medicines Initiative programme integrating nine projects with the shared goal of progressing the development of new…”
Get full text

Ethical approval for controlled human infectious model clinical trial protocols – A workshop report by Jamrozik, Euzebiusz, Littler, Katherine, Meln, Irina, Van Molle, Wim, Morel, Sandra, Olesen, Ole F., Rubbrecht, Michelle, Balasingam, Shobana, Neels, Pieter

“…Controlled Human Infectious Model studies (CHIM) involve deliberately exposing volunteers to pathogens. To discuss ethical issues related to CHIM, the European…”
Get full text

Parasitic and parachute research in global health by Bockarie, Moses, Machingaidze, Shingai, Nyirenda, Thomas, Olesen, Ole F, Makanga, Michael

Get full text

Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time by Kenny, Grace, O’Reilly, Sophie, Wrigley Kelly, Neil, Negi, Riya, Gaillard, Colette, Alalwan, Dana, Saini, Gurvin, Alrawahneh, Tamara, Francois, Nathan, Angeliadis, Matthew, Garcia Leon, Alejandro Abner, Tinago, Willard, Feeney, Eoin R., Cotter, Aoife G., de Barra, Eoghan, Yousif, Obada, Horgan, Mary, Doran, Peter, Stemler, Jannik, Koehler, Philipp, Cox, Rebecca Jane, O’Shea, Donal, Olesen, Ole F., Landay, Alan, Hogan, Andrew E., Lelievre, Jean-Daniel, Gautier, Virginie, Cornely, Oliver A., Mallon, Patrick W. G.

“…SARS-CoV-2 neutralising antibodies provide protection against COVID-19. Evidence from early vaccine trials suggested binding antibody thresholds could serve as…”
Get full text

Vaccine adjuvants: scientific challenges and strategic initiatives by Harandi, Ali M, Davies, Gwyn, Olesen, Ole F

“…The majority of vaccine antigens currently under investigation represent recombinant molecules or subunits of pathogens with little or no inherent…”
Get more information

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023 by Cavaleri, Marco, Kaslow, David, Boateng, Eric, Chen, Wilbur H., Chiu, Christopher, Choy, Robert K.M., Correa-Oliveira, Rodrigo, Durbin, Anna, Egesa, Moses, Gibani, Malick, Kapulu, Melissa, Katindi, Melba, Olotu, Ally, Pongsuwan, Pongphaya, Simuyandi, Michelo, Speder, Bruno, Talaat, Kawsar R., Weller, Charlie, Wills, Bridget, Baay, Marc, Balasingam, Shobana, Olesen, Ole F., Neels, Pieter

“…Many aspects of Controlled Human Infection Models (CHIMs, also known as human challenge studies and human infection studies) have been discussed extensively,…”
Get full text

Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report by Corti, Nicoletta, Chiu, Christopher, Cox, Rebecca J., Demont, Clarisse, Devaster, Jeanne-Marie, Engelhardt, Othmar G., Gorringe, Andrew, Hassan, Khaole, Hoefnagel, Marcel, Kamerling, Ingrid, Krut, Oleg, Lane, Chelsea, Liebers, Reinhard, Luke, Catherine, Van Molle, Wim, Morel, Sandra, Neels, Pieter, Roestenberg, Meta, Rubbrecht, Michelle, Klaas Smits, Wiep, Stoughton, Daniel, Talaat, Kawsar, Vehreschild, Maria J.G.T., Wildfire, Adrian, Meln, Irina, Olesen, Ole F.

“…Within the Innovative Health Initiative (IHI) Inno4Vac CHIMICHURRI project, a regulatory workshop was organised on the development and manufacture of challenge…”
Get full text

Funders' Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries by Cardoso-Weinberg, Ana, Alley, Chris, Kupfer, Linda E, Aslanyan, Garry, Makanga, Michael, Zicker, Fabio, Olesen, Ole F

“…We identify and discuss 7 approaches for funders to contemplate when considering support for implementation research in low- and middle-income countries…”
Get full text

New hope for tuberculosis vaccines by Olesen, Ole F, Abdullah, Fareed, Coppens, Rene, Gardner, Peter J, Ginsberg, Ann M, Hanekom, Willem A, Laang, Hannu, Lewinsohn, David M, Loots, Glaudina, Schmidt, Alexander, Vekemans, Johan, Voss, Gerald H

“…An efficacy of 45·4% (95% CI 6·4–68·1; p=0·03) was shown against a secondary endpoint: sustained conversion of the QuantiFERON-TB gold in-tube test, which…”
Get full text

Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection by Byrne, Joanne, Gu, Lili, Garcia-Leon, Alejandro, Gaillard, Colette Marie, Saini, Gurvin, Alalwan, Dana, Tomás-Cortázar, Julen, Kenny, Grace, Donohue, Sean, Reynolds, Bearach, O'Gorman, Tessa, Landay, Alan, Doran, Peter, Stemler, Jannik, Koehler, Philipp, Cox, Rebecca Jane, Olesen, Ole F, Lelievre, Jean-Daniel, O'Broin, Cathal, Savinelli, Stefano, Feeney, Eoin R, O'Halloran, Jane A, Cotter, Aoife, Horgan, Mary, Kelly, Christine, Sadlier, Corrina, de Barra, Eoghan, Cornely, Oliver A, Gautier, Virginie, Mallon, Patrick Wg

“…A clear immune correlate of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has not been defined. We explored antibody,…”
Get full text

Health research in Africa: getting priorities right by Olesen, Ole F., Iqbal Parker, M.

“…Le profil des maladies en Afrique subsaharienne change et de nombreux pays sont confrontés à une nouvelle et croissante menace par des maladies non…”
Get full text